DermaSensor Inc. raises $16M in Series B funding to expand its FDA-cleared skin cancer detection technology, backed by investors like Pier 70 Ventures and Kern Venture Group.
Amount Raised
$16 Million
Round Type
Series B
WilmingtonOtherHealthcareHealth CareInvestors
Description
DermaSensor Inc. has raised $16 million in Series B funding to advance its FDA-cleared skin cancer detection solution. The investment includes contributions from existing and new investors, totaling $43 million for the company. With strong market traction, the company aims to enhance early cancer detection in primary care settings
Quick answer
DermaSensor raised $16 Million in a Series B round, dated October 2, 2025. Investors: GenHenn Capital, Kern Venture Group and Pier 70 Ventures. DermaSensor is based in Wilmington, Delaware, United States.
- How much did DermaSensor raise?
- DermaSensor raised $16 Million in a Series B round on October 2, 2025.
- Who invested in DermaSensor?
- GenHenn Capital, Kern Venture Group and Pier 70 Ventures are named as investors in this round.
- What does DermaSensor do?
- DermaSensor Inc. is a health technology company designing tools to better equip primary care providers for skin cancer checks
- Where is DermaSensor based and how big is it?
- DermaSensor is based in Wilmington, Delaware, United States. Fundz records about 33 employees.
- Who are the decision-makers at DermaSensor?
- Fundz holds 5 contacts at DermaSensor, including the Co-Founder & CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Health Care around the same time
Companies in the same sectors as DermaSensor that raised within 45 days of this round, from Fundz verified event records.
- BTB Therapeutics raised $3.4M on November 14, 2025.
- Huxley Medical, Inc. raised $5.9M on November 14, 2025.
- Ablative Solutions raised $10M on November 14, 2025.
- Clairity raised $43M (Series B) on November 13, 2025.
- Jaguar Health raised $11M on November 12, 2025.
- Damora Therapeutics, Inc. raised $285M on November 12, 2025.
Who to call at DermaSensor, and when
A new round usually means DermaSensor is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day DermaSensor raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at DermaSensor, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at DermaSensor. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment DermaSensor raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansDermaSensor raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.